Jennifer L. Herron

Senior Vice President and Chief Commercial Officer at ADC Therapeutics

Jennifer Herron has served on our board of directors since June 2022. Since November 2019, Ms. Herron has served as Senior Vice President and Chief Commercial Officer of ADC Therapeutics. Before joining ADC Therapeutics, Ms. Herron held Chief Commercial Officer/Global Commercial Head roles at Immunogen, MorphoSys and Ariad Pharmaceuticals, preparing for commercial launches in oncology. Earlier in her career, she held commercial leadership roles of increasing responsibility across multiple therapeutics areas including over 20 years with Bristol-Myers Squibb, Novartis Oncology, and SmithKline Beecham Oncology (GlaxoSmithKline). Ms. Herron holds an MBA from Georgetown University and a BA in Biology and Economics from Lehigh University.